BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...contributors are French investors; the remainder are international institutional investors. Investors include Obratori (L’Occitane Group), Guerbet S.A....
BioCentury | Sep 25, 2019
Company News

Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson

...tiered royalties on sales. Guerbet, IBM Watson to co-develop AI product for prostate cancer France’s Guerbet S.A....
...cancer screening assay (Informal), Cologuard (Other) Bayer AG GW Pharmaceuticals plc Bavarian Nordic A/S Exact Sciences Corp. Takeda Pharmaceutical Co. Ltd. Guerbet S.A. IBM...
BioCentury | Jan 12, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...firm said it remains on track to raise the remaining funds this year. New investors Guerbet S.A....
BioCentury | Jan 10, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...firm said it remains on track to raise the remaining funds this year. New investors Guerbet S.A....
BioCentury | Oct 13, 2017
Clinical News

FDA approves Dotarem imaging agent in patients ages <2

...FDA approved Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) for use in MRI imaging to detect and...
...25, 2013 ). Guerbet S.A. (Euronext:GBT), Villepinte, France Product: Dotarem gadoterate meglumine Business: Diagnostic Elizabeth S. Eaton Dotarem gadoterate meglumine Guerbet S.A....
BioCentury | Mar 17, 2017
Clinical News

Linear gadolinium contrast agents regulatory update

...signs of harm.” The agents are gadobenic acid, gadodiamide, gadopentetic acid and Optimark gadoversetamide from Guerbet S.A....
...gadolinium. European Medicines Agency (EMA) , London, U.K. Product: Linear gadolinium contrast agents Business: Diagnostic Alicia Parker gadoversetamide Optimark Guerbet S.A....
BioCentury | Oct 19, 2015
Company News

Guerbet, Shanghai Pharma deal

...Lipiodol is registered in China to treat iodine deficiency and to be used in lymphography. Guerbet S.A....
BioCentury | Apr 21, 2014
Clinical News

Lipiodol ethiodized oil regulatory update

...FDA approved an sNDA from Guerbet for Lipiodol ethiodized oil for selective hepatic intra-arterial use for...
...to reference data on safety and efficacy from scientific literature or from previously approved products. Guerbet S.A....
BioCentury | Mar 31, 2014
Company News

Guerbet, Sirtex Medical deal

...The companies partnered to develop Sirtex's SIR-Spheres microspheres and Guerbet's Lipiodol ethiodized oil to be used...
...computed tomography of the liver to visualize and localize lesions in adults with known HCC. Guerbet S.A....
BioCentury | Nov 4, 2013
Clinical News

Lipiodol ethiodized oil regulatory update

...FDA granted Orphan Drug designation to Guerbet's Lipiodol ethiodized oil to manage patients with known hepatocellular...
...to prevent iodine deficiency disorders when iodization of salt or drinking water cannot be undertaken. Guerbet S.A....
Items per page:
1 - 10 of 27
BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...contributors are French investors; the remainder are international institutional investors. Investors include Obratori (L’Occitane Group), Guerbet S.A....
BioCentury | Sep 25, 2019
Company News

Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson

...tiered royalties on sales. Guerbet, IBM Watson to co-develop AI product for prostate cancer France’s Guerbet S.A....
...cancer screening assay (Informal), Cologuard (Other) Bayer AG GW Pharmaceuticals plc Bavarian Nordic A/S Exact Sciences Corp. Takeda Pharmaceutical Co. Ltd. Guerbet S.A. IBM...
BioCentury | Jan 12, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...firm said it remains on track to raise the remaining funds this year. New investors Guerbet S.A....
BioCentury | Jan 10, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...firm said it remains on track to raise the remaining funds this year. New investors Guerbet S.A....
BioCentury | Oct 13, 2017
Clinical News

FDA approves Dotarem imaging agent in patients ages <2

...FDA approved Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) for use in MRI imaging to detect and...
...25, 2013 ). Guerbet S.A. (Euronext:GBT), Villepinte, France Product: Dotarem gadoterate meglumine Business: Diagnostic Elizabeth S. Eaton Dotarem gadoterate meglumine Guerbet S.A....
BioCentury | Mar 17, 2017
Clinical News

Linear gadolinium contrast agents regulatory update

...signs of harm.” The agents are gadobenic acid, gadodiamide, gadopentetic acid and Optimark gadoversetamide from Guerbet S.A....
...gadolinium. European Medicines Agency (EMA) , London, U.K. Product: Linear gadolinium contrast agents Business: Diagnostic Alicia Parker gadoversetamide Optimark Guerbet S.A....
BioCentury | Oct 19, 2015
Company News

Guerbet, Shanghai Pharma deal

...Lipiodol is registered in China to treat iodine deficiency and to be used in lymphography. Guerbet S.A....
BioCentury | Apr 21, 2014
Clinical News

Lipiodol ethiodized oil regulatory update

...FDA approved an sNDA from Guerbet for Lipiodol ethiodized oil for selective hepatic intra-arterial use for...
...to reference data on safety and efficacy from scientific literature or from previously approved products. Guerbet S.A....
BioCentury | Mar 31, 2014
Company News

Guerbet, Sirtex Medical deal

...The companies partnered to develop Sirtex's SIR-Spheres microspheres and Guerbet's Lipiodol ethiodized oil to be used...
...computed tomography of the liver to visualize and localize lesions in adults with known HCC. Guerbet S.A....
BioCentury | Nov 4, 2013
Clinical News

Lipiodol ethiodized oil regulatory update

...FDA granted Orphan Drug designation to Guerbet's Lipiodol ethiodized oil to manage patients with known hepatocellular...
...to prevent iodine deficiency disorders when iodization of salt or drinking water cannot be undertaken. Guerbet S.A....
Items per page:
1 - 10 of 27